AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 66 filers reported holding AVROBIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $218,000 | -50.5% | 137,908 | +2.8% | 0.00% | – |
| Q4 2021 | $440,000 | -58.4% | 134,127 | -21.6% | 0.00% | – |
| Q3 2021 | $1,057,000 | -29.4% | 170,996 | +1.6% | 0.00% | – |
| Q2 2021 | $1,497,000 | -11.9% | 168,364 | +25.8% | 0.00% | -100.0% |
| Q1 2021 | $1,699,000 | -18.3% | 133,847 | -10.3% | 0.00% | 0.0% |
| Q4 2020 | $2,079,000 | +11.1% | 149,140 | +3.8% | 0.00% | 0.0% |
| Q3 2020 | $1,871,000 | -24.5% | 143,738 | +1.2% | 0.00% | 0.0% |
| Q2 2020 | $2,478,000 | +12.2% | 142,014 | +0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,209,000 | -22.2% | 141,996 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $2,840,000 | +25.6% | 141,108 | -11.9% | 0.00% | 0.0% |
| Q3 2019 | $2,261,000 | +114.5% | 160,110 | +147.1% | 0.00% | – |
| Q2 2019 | $1,054,000 | – | 64,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,417,204 | $28,528,000 | 17.28% |
| Aisling Capital Management LP | 893,079 | $17,978,000 | 6.89% |
| AlpInvest Partners B.V. | 200,732 | $4,041,000 | 3.44% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $20,130,000 | 2.40% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $6,352,000 | 1.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,164,970 | $23,451,000 | 0.75% |
| Eventide Asset Management | 1,305,307 | $26,276,000 | 0.74% |
| Camber Capital Management LP | 600,000 | $12,078,000 | 0.62% |
| EMERALD ADVISERS, LLC | 656,306 | $13,211,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 641,387 | $12,911,000 | 0.53% |